Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Current Opinion in Cardiology
|
May 27, 2020
Hypertension in the elderly: recent developments and insights
Hillel Sternlicht, Jan Basile
Current Hypertension Reports
|
February 13, 2019
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
Hillel Sternlicht, George L Bakris
The Medical Clinics of North America
|
November 26, 2016
The Kidney in Hypertension
Hillel Sternlicht, George L Bakris
Blood Purification
|
January 15, 2016
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Hillel Sternlicht, George L Bakris
Therapeutics and Clinical Risk Management
|
December 18, 2015
Hypercalcemia of malignancy and new treatment options
Hillel Sternlicht, Ilya G Glezerman
Current Diabetes Reports
|
April 20, 2022
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
Scott Cohen, Hillel Sternlicht, George L Bakris
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Current Opinion in Cardiology
|
May 27, 2020
Hypertension in the elderly: recent developments and insights
Hillel Sternlicht, Jan Basile
Current Hypertension Reports
|
February 13, 2019
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
Hillel Sternlicht, George L Bakris
The Medical Clinics of North America
|
November 26, 2016
The Kidney in Hypertension
Hillel Sternlicht, George L Bakris
Blood Purification
|
January 15, 2016
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Hillel Sternlicht, George L Bakris
Therapeutics and Clinical Risk Management
|
December 18, 2015
Hypercalcemia of malignancy and new treatment options
Hillel Sternlicht, Ilya G Glezerman
Current Diabetes Reports
|
April 20, 2022
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
Scott Cohen, Hillel Sternlicht, George L Bakris
Page
of 1